Nadine Abi-Jaoudeh

Dr. Abi-Jaoudeh is an American and Canadian board-certified vascular and interventional radiologist at the University of California Irvine. Dr. Abi-Jaoudeh earned her medical degree from the University of Montreal and completed internship and residency at the University of Laval in Québec, Canada a fellowship in interventional radiology at the University of Virginia in Charlottesville, Va. She then joined National Institutes of Health where she was a principal and associate investigator on several human trials. She also completed multiple animal and translational studies. In 2015, Dr. Abi-Jaoudeh joined the University of California Irvine where she has grown the research program. In 2018, she became the director of Clinical research of the department of Radiology and in 2020 she became the chief of Interventional radiology section. She is principal investigator on multiple Phase I, II and III trials.
She has authored multiple manuscripts and submitted two patents related to imaging technology in the angiography suite. Her research interests include fusion and functional imaging during image guided procedures, innovative therapeutic methods to treat metastatic and primary liver disease. Her goal is to grow a translational research program to improve UCI patient care and outcome.
Dr Abi-Jaoudeh is a fellow of the Society of Interventional Radiology, a member of the Royal Canadian College of Radiology and deputy editor of the Journal of Vascular and Interventional Radiology. She is also on the scientific committee of the Society of Interventional Radiology annual meeting and the chair of the clinical trials and registries committees.



Focused Symposium: Liver Cancer Fundamentals

Friday, September 20, 2024
8:20 AM - 10:00 AM

Use of Software for Ablation Planning and Confirmation: My Top 5 Pearls

Friday, September 20, 2024
5:40 PM - 5:45 PM

Radioopaque Y90 Microspheres: Current Status and Potential Advantages

Saturday, September 21, 2024
9:44 AM - 9:51 AM

Liquid Embolics in Oncology: Potential Future Applications

Saturday, September 21, 2024
10:12 AM - 10:19 AM

Bilobar colorectal cancer hepatic metastatic disease: Y90 vs HAI pump

Saturday, September 21, 2024
5:13 PM - 5:22 PM

Which Drugs to Watch Out For

Sunday, September 22, 2024
9:16 AM - 9:24 AM